Vall d'Hebron Talks by VHIR 'Genome Editing in Biomedicine in 2023'

 Vall d'Hebron Talks by VHIR
  Activitat Online —
01/10/2024
01/10/2024 -- From 11:00h to 12:00h
Organize :
Vall d'Hebron Institut de Recerca (VHIR)
Modality: Online
Share it:
Genome Editing in Biomedicine in 2023

Online seminar organized by Dr. Josep Quer within Translational Biomedical Research Master’s Degree’s Module 1, Transversal Skills for Translational Research in Human Pathology.

Speaker: Dr. Lluis Montoliu, PhD, Research Scientist CSIC -Centro Nacional de Biotecnologia (CNB)

🕚 11 a.m. – 12h p.m.

      Access here

Related activities

III Curso Impacto de las nuevas Tecnologías en el Control de la Diabetes

11/27/2024 - 15:00
Cursos
More information

V Curso nacional de rehabilitación en las deformidades del Raquis

Sala de actos planta 0, Hospital de Traumatología Hospital Vall d´Hebron Pg. de la Vall d´Hebron, 119, 08035 Barcelona
11/28/2024 - 09:00
Cursos
More information

Congress: Translational research in HNSCC: New challenges for future therapies

12/02/2024 - 09:00
Jornades
More information

Avances en estimulación cardíaca y sistemas implantables XXXIV edición

12/02/2024 - 08:45
Cursos
More information

Subscribe to our newsletters and be a part of Campus Life

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.